首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺癌新辅助化疗再认识
引用本文:黄焰, 曾敏. 乳腺癌新辅助化疗再认识[J]. 中国肿瘤临床, 2016, 43(15): 643-645. DOI: 10.3969/j.issn.1000-8179.2016.15.419
作者姓名:黄焰  曾敏
作者单位:作者单位:军事医学科学院附属医院乳腺外科(北京市100039)
摘    要:近年来随着乳腺癌新辅助化疗研究的深入,该治疗手段已在临床被广泛应用。新辅助化疗使不可手术的局部晚期乳腺癌患者获得手术治疗的机会,并且提高具有较大肿瘤体积患者的保乳率,从而明显改善患者的生存质量,但仍有许多问题存在争议。本文将对乳腺癌新辅助化疗相关临床研究、以及对新辅助化疗的再认识进行综述。

关 键 词:乳腺癌  新辅助化疗  临床研究
收稿时间:2016-04-13
修稿时间:2016-06-29

Reconsidering the use of neoadjuvant chemotherapy in breast cancer
Yan HUANG, Min ZENG. Reconsidering the use of neoadjuvant chemotherapy in breast cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 43(15): 643-645. DOI: 10.3969/j.issn.1000-8179.2016.15.419
Authors:Yan HUANG  Min ZENG
Affiliation:Department of Breast Surgery, Affiliated Hospital of Military Academy of Medical Sciences of PLA, Beijing100039, China
Abstract:With the intense development of neoadjuvant chemotherapy for breast cancer research in recent years, this approach has been used widely in clinical treatment. Neoadjuvant chemotherapy can increase the chance of operation for patients with local y advanced breast cancer. Moreover, it can improve breast-conserving rate in larger-tumor patients, thereby improving the quality of life of these patients. However, some controversies regarding the use of neoadjuvant chemotherapy for breast cancer patients remain to be resolved. This review focuses on clinical studies and re-recognition of neoadjuvant chemotherapy as a viable treatment for breast cancer.
Keywords:breast cancer  neoadjuvant chemotherapy  clinical studies
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号